Marker Therapeutics Inc (MRKR) — Financial Flexibility Index
Marker Therapeutics Inc (MRKR) has a Financial Flexibility Index of -0.39x as of March 2026. Free cash flow of $-1.40 Million (operating CF $-1.40 Million minus capex $2.00) represents 0% of total liabilities ($3.64 Million). Check Marker Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Marker Therapeutics Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Marker Therapeutics Inc across 27 annual periods. See Marker Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Marker Therapeutics Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Marker Therapeutics Inc. For the full company profile including market capitalisation, see MRKR stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.28x | $-12.01 Million | $-12.01 Million | $2.27 Million | ▼ -67.7% |
| 2024 | -3.15x | $-10.91 Million | $-10.91 Million | $3.46 Million | ▲ +41.1% |
| 2023 | -5.35x | $-16.44 Million | $-16.44 Million | $3.07 Million | ▼ -193.8% |
| 2022 | -1.82x | $-26.97 Million | $-26.97 Million | $14.82 Million | ▼ -82.0% |
| 2021 | -1.00x | $-24.15 Million | $-27.28 Million | $24.15 Million | ▼ -69.4% |
| 2020 | -0.59x | $-10.78 Million | $-20.03 Million | $18.27 Million | ▲ +92.5% |
| 2019 | -7.88x | $-17.91 Million | $-18.28 Million | $2.27 Million | ▼ -54.1% |
| 2018 | -5.11x | $-14.33 Million | $-14.48 Million | $2.80 Million | ▲ +6.1% |
| 2017 | -5.45x | $-8.29 Million | $-8.44 Million | $1.52 Million | ▼ -48.7% |
| 2016 | -3.66x | $-6.36 Million | $-6.51 Million | $1.74 Million | ▼ -2345.1% |
| 2015 | -0.15x | $-4.20 Million | $-4.34 Million | $28.01 Million | ▲ +91.5% |
| 2014 | -1.75x | $-2.19 Million | $-2.19 Million | $1.25 Million | ▼ -2131.6% |
| 2013 | -0.08x | $-694.58K | $-694.58K | $8.85 Million | ▲ +71.0% |
| 2012 | -0.27x | $-1.57 Million | $-1.57 Million | $5.77 Million | ▲ +21.3% |
| 2011 | -0.34x | $-1.31 Million | $-1.31 Million | $3.80 Million | ▼ -26.3% |
| 2010 | -0.27x | $-925.04K | $-925.04K | $3.39 Million | ▲ +76.0% |
| 2009 | -1.14x | $-1.12 Million | $-1.12 Million | $986.35K | ▼ -405.6% |
| 2008 | -0.22x | $-692.00K | $-714.42K | $3.08 Million | ▲ +63.5% |
| 2007 | -0.62x | $-1.20 Million | $-1.23 Million | $1.95 Million | ▼ -63.8% |
| 2006 | -0.38x | $-1.19 Million | $-1.19 Million | $3.15 Million | ▲ +25.3% |
| 2005 | -0.50x | $-1.16 Million | $-1.16 Million | $2.31 Million | ▼ -4.8% |
| 2004 | -0.48x | $-1.21 Million | $-1.21 Million | $2.53 Million | ▲ +86.3% |
| 2003 | -3.51x | $-2.59 Million | $-2.59 Million | $736.95K | ▲ +25.9% |
| 2002 | -4.74x | $-1.40 Million | $-1.41 Million | $295.60K | ▼ -34597.9% |
| 2001 | 0.01x | $2.38K | $2.38K | $173.03K | ▲ +101.1% |
| 2000 | -1.28x | $-876.88K | $-879.74K | $682.74K | ▲ +51.1% |
| 1999 | -2.63x | $-761.15K | $-815.18K | $289.71K | — |